Top Oral Anti Diabetic Drug Companies in Asia-Pacific

  1. Sanofi

  2. Novo Nordisk

  3. Takeda Pharmaceuticals

  4. Astellas Pharma

  5. AstraZeneca

*免責事項：上位企業は順不同

アジア太平洋地域経口抗糖尿病薬市場 主要プレーヤー

Asia-Pacific Oral Anti-Diabetic Drug - Competitive Concentration

アジア太平洋地域経口抗糖尿病薬市場 集中度

List of Oral Anti Diabetic Drug Companies in Asia-Pacific

  • Takeda Pharmaceuticals

  • Novo Nordisk

  • Pfizer

  • Eli Lilly and Company

  • Janssen Global Services LLC

  • Astellas Pharma

  • Boehringer Ingelheim

  • Merck

  • AstraZeneca

  • Bristol-Myers Squibb

  • Novartis

  • Sanofi

Get more insights on Asia-Pacific Oral Anti-Diabetic Drug industry from our comprehensive report